| __timestamp | Dynavax Technologies Corporation | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 396000000 |
| Thursday, January 1, 2015 | 86943000 | 364000000 |
| Friday, January 1, 2016 | 84493000 | 376000000 |
| Sunday, January 1, 2017 | 64988000 | 382000000 |
| Monday, January 1, 2018 | 74951000 | 432000000 |
| Tuesday, January 1, 2019 | 62331000 | 457000000 |
| Wednesday, January 1, 2020 | 28607000 | 463000000 |
| Friday, January 1, 2021 | 32228000 | 508000000 |
| Saturday, January 1, 2022 | 46600000 | 539000000 |
| Sunday, January 1, 2023 | 54886000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Zoetis Inc. and Dynavax Technologies Corporation have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Zoetis consistently allocated a significant portion of its budget to R&D, with expenditures peaking at approximately $614 million in 2023, marking a 55% increase from 2014. In contrast, Dynavax's R&D spending showed a more volatile trend, with a notable dip in 2020 to around $29 million, before recovering to $55 million in 2023. This fluctuation reflects the challenges and strategic shifts within smaller biotech firms. As Zoetis continues to lead with robust R&D investments, Dynavax's adaptive strategy highlights the dynamic nature of the biotech sector, where innovation is both a challenge and an opportunity.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Zoetis Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Dynavax Technologies Corporation
Research and Development Investment: Corcept Therapeutics Incorporated vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?